N/A N=57 Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
HIV Infections · Human Papillomavirus Infection · Cervical Cancer
Primary: Prevalence of Abnormal Cervical Cytology — 12 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=208 Use of the Guardian™ Connect System With Smart Connected Devices
Type 1 Diabetes Mellitus
Primary: Percentage of Time in Hypoglycemia — 3.1; 2.7 percentage of time
Phase 3 N=1,489 A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
Stroke
Primary: Percentage of Participants With Modified Rankin Scale (mRS) Score of 0 or 1 — 72.7; 70.3 Percentage of participants
N/A N=27 A Mobile Tai Chi Platform for Fall Prevention in Older Adults - Phase II
Healthy Aging
Primary: Protocol Adherence — 76.81 percentage of session completed
N/A N=9 TMS Alteration of the Reward Positivity
Anhedonia
Primary: Reward Positivity — 2.21; .29 femtoteslas
Phase 2 N=35 Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Primary: Complete Response Rate — 21; 9; 2 Participants
N/A N=30 Kalifilcon A Toric Compared to Commercially Available Lenses
Astigmatism
Primary: Primary Gaze Orientation for 5 Minutes — 3.3; 2.8; 2.4; 3.6 degrees
Phase 2 N=399 A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
COVID-19
Primary: COVID-19 Prophylaxis — 30; 105 Participants
Phase 4 N=60 SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
Surgery · Surgical Site Infection · Cutibacterium Acnes
Primary: Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep — 11; 9; 6 Participants — p=0.275
N/A N=12 Optimizing Prosthetic and Bicycle Fit for Veterans With Transtibial Amputations
Amputation
Primary: Mechanical Crank Power Output — 0.59; 0.99; 0.60; 0.97 W/kg
N/A N=92 A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming
Amblyopia · Ocular Motility Disorders
Primary: Visual Acuity — -0.12; -0.13 change in logMAR
Phase 1 N=16 Safety of Intravenous Apramycin in Adults
Bacterial Infection
Primary: Area Under the Concentration-time Curve From Time Zero to 8 h (AUC 0-8) of Total Apramycin in Epithelial Lining Fluid (ELF) and Alveolar Macrophage (AM) — 142.8; 131.7…
N/A N=42 PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Esophagogastric Cancer
Primary: Safety as Measured by the Number of Participants Who Experienced Toxicity — 2; 34 Participants
Phase 2 N=18 Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
Metastatic Carcinoma in the Adrenal Cortex · Stage III Adrenal Cortex Carcinoma AJCC v8 · Stage IV Adrenal Cortex Carcinoma AJCC v8
Primary: Progression-free Survival (PFS) as Defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 Criteria — 72.2 precentage of participants
Phase 4 N=94 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
COVID-19 · Venous Thromboses · Arterial Thrombosis
Primary: Total Number of Patients Who Were Alive and Without Venous/Thrombotic Events in ICU — 28; 31 Participants